| Target Price | ₩1,346,400.00 | 
| Price | ₩1,000,000.00 | 
| Potential | 
      
            
    
      
    
  34.64%
     register free of charge | 
| Number of Estimates | 29 | 
| 29 Analysts have issued a price target SAMSUNG BIOLOGICS 2026 .
        The average SAMSUNG BIOLOGICS target price is ₩1,346,400.00.
        This is 
       
    
      
    
  34.64%
     register free of charge 
                ₩1,680,000.00 
    
      
    
  68.00%
     register free of charge 
                ₩1,161,500.00 
    
      
    
  16.15%
     register free of charge | |
| A rating was issued by 31 analysts: 30 Analysts recommend SAMSUNG BIOLOGICS to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the SAMSUNG BIOLOGICS stock has an average upside potential 2026 of 
       
    
      
    
  34.64%
     register free of charge | 
| Dec '24 | 2025 Estimates | |
|---|---|---|
| Revenue Billion ₩ | 4,547.32 | 5,755.97 | 
| 23.08% | 26.58% | |
| EBITDA Margin | 30.05% | 43.82% | 
| 3.11% | 45.85% | |
| Net Margin | 23.82% | 25.84% | 
| 2.62% | 8.47% | 
29 Analysts have issued a sales forecast SAMSUNG BIOLOGICS 2025 . The average SAMSUNG BIOLOGICS sales estimate is
This results in the following potential growth metrics:
28 Analysts have issued an SAMSUNG BIOLOGICS EBITDA forecast 2025. The average SAMSUNG BIOLOGICS EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
29 SAMSUNG BIOLOGICS Analysts have issued a net profit forecast 2025. The average SAMSUNG BIOLOGICS net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 | 2025 Estimates | |
|---|---|---|
| Earnings Per Share ₩ | 15,220.67 | 20,895.66 | 
| 26.31% | 37.28% | |
| P/E | 47.86 | |
| EV/Sales | 15.06 | 
29 Analysts have issued a SAMSUNG BIOLOGICS forecast for earnings per share. The average SAMSUNG BIOLOGICS EPS is
This results in the following potential growth metrics and future valuations:
SAMSUNG BIOLOGICS...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


